Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6A52
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,968
Award facts
- Contract value 100% obligated
- $36,967.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $36,967.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 200 mg/1.14 mL syringes on January 28, 2026, with an ultimate completion date of January 29, 2026. The contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to deliver a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, operating as a subsidiary of parent company Cencora, Inc. The company maintains a significant federal contract portfolio focused on supplying prescription medications, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This contract award demonstrates the company's continued capability to fulfill federal medical procurement requirements through open competition and competitively awarded delivery orders under its primary DLA pharmaceutical supply vehicle.
Quick answers
Who was awarded contract SPE2DR26F6A52?
SPE2DR26F6A52 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F6A52 worth?
The government has obligated $36,968 on SPE2DR26F6A52.
Is contract SPE2DR26F6A52 an order under another contract?
Yes. SPE2DR26F6A52 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F6A52 competed?
The extent of competition for SPE2DR26F6A52 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award